TRIM69 Inhibits Vesicular Stomatitis Indiana Virus. 2019

Suzannah J Rihn, and Muhamad Afiq Aziz, and Douglas G Stewart, and Joseph Hughes, and Matthew L Turnbull, and Mariana Varela, and Elena Sugrue, and Christie S Herd, and Megan Stanifer, and Steven P Sinkins, and Massimo Palmarini, and Sam J Wilson
MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.

Vesicular stomatitis Indiana virus (VSIV), formerly known as vesicular stomatitis virus (VSV) Indiana (VSVIND), is a model virus that is exceptionally sensitive to the inhibitory action of interferons (IFNs). Interferons induce an antiviral state by stimulating the expression of hundreds of interferon-stimulated genes (ISGs). These ISGs can constrain viral replication, limit tissue tropism, reduce pathogenicity, and inhibit viral transmission. Since VSIV is used as a backbone for multiple oncolytic and vaccine strategies, understanding how ISGs restrict VSIV not only helps in understanding VSIV-induced pathogenesis but also helps us evaluate and understand the safety and efficacy of VSIV-based therapies. Thus, there is a need to identify and characterize the ISGs that possess anti-VSIV activity. Using arrayed ISG expression screening, we identified TRIM69 as an ISG that potently inhibits VSIV. This inhibition was highly specific as multiple viruses, including influenza A virus, HIV-1, Rift Valley fever virus, and dengue virus, were unaffected by TRIM69. Indeed, just one amino acid substitution in VSIV can govern sensitivity/resistance to TRIM69. Furthermore, TRIM69 is highly divergent in human populations and exhibits signatures of positive selection that are consistent with this gene playing a key role in antiviral immunity. We propose that TRIM69 is an IFN-induced inhibitor of VSIV and speculate that TRIM69 could be important in limiting VSIV pathogenesis and might influence the specificity and/or efficacy of vesiculovirus-based therapies.IMPORTANCE Vesicular stomatitis Indiana virus (VSIV) is a veterinary pathogen that is also used as a backbone for many oncolytic and vaccine strategies. In natural and therapeutic settings, viral infections like VSIV are sensed by the host, and as a result the host cells make proteins that can protect them from viruses. In the case of VSIV, these antiviral proteins constrain viral replication and protect most healthy tissues from virus infection. In order to understand how VSIV causes disease and how healthy tissues are protected from VSIV-based therapies, it is crucial that we identify the proteins that inhibit VSIV. Here, we show that TRIM69 is an antiviral defense that can potently and specifically block VSIV infection.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D003716 Dengue Virus A species of the genus FLAVIVIRUS which causes an acute febrile and sometimes hemorrhagic disease in man. Dengue is mosquito-borne and four serotypes are known. Breakbone Fever Virus,Breakbone Fever Viruses,Dengue Viruses,Fever Virus, Breakbone,Fever Viruses, Breakbone,Virus, Breakbone Fever,Virus, Dengue,Viruses, Breakbone Fever,Viruses, Dengue
D005810 Multigene Family A set of genes descended by duplication and variation from some ancestral gene. Such genes may be clustered together on the same chromosome or dispersed on different chromosomes. Examples of multigene families include those that encode the hemoglobins, immunoglobulins, histocompatibility antigens, actins, tubulins, keratins, collagens, heat shock proteins, salivary glue proteins, chorion proteins, cuticle proteins, yolk proteins, and phaseolins, as well as histones, ribosomal RNA, and transfer RNA genes. The latter three are examples of reiterated genes, where hundreds of identical genes are present in a tandem array. (King & Stanfield, A Dictionary of Genetics, 4th ed) Gene Clusters,Genes, Reiterated,Cluster, Gene,Clusters, Gene,Families, Multigene,Family, Multigene,Gene Cluster,Gene, Reiterated,Multigene Families,Reiterated Gene,Reiterated Genes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000070584 Tripartite Motif Proteins A protein family defined by the presence of three ZINC FINGER domains, one of which is a RING FINGER DOMAIN, a coiled-coil region, and a highly variable C-terminal region. They function in many cellular processes including APOPTOSIS and CELL CYCLE regulation. RBCC Protein,TRIM Protein,Tripartite Motif Protein,RBCC Protein Family,RBCC Proteins,TRIM Protein Family,TRIM Proteins,Family, RBCC Protein,Family, TRIM Protein,Motif Protein, Tripartite,Motif Proteins, Tripartite,Protein Family, RBCC,Protein Family, TRIM,Protein, RBCC,Protein, TRIM,Protein, Tripartite Motif,Proteins, RBCC,Proteins, TRIM,Proteins, Tripartite Motif
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

Suzannah J Rihn, and Muhamad Afiq Aziz, and Douglas G Stewart, and Joseph Hughes, and Matthew L Turnbull, and Mariana Varela, and Elena Sugrue, and Christie S Herd, and Megan Stanifer, and Steven P Sinkins, and Massimo Palmarini, and Sam J Wilson
December 2019, Journal of virology,
Suzannah J Rihn, and Muhamad Afiq Aziz, and Douglas G Stewart, and Joseph Hughes, and Matthew L Turnbull, and Mariana Varela, and Elena Sugrue, and Christie S Herd, and Megan Stanifer, and Steven P Sinkins, and Massimo Palmarini, and Sam J Wilson
July 1979, Acta virologica,
Suzannah J Rihn, and Muhamad Afiq Aziz, and Douglas G Stewart, and Joseph Hughes, and Matthew L Turnbull, and Mariana Varela, and Elena Sugrue, and Christie S Herd, and Megan Stanifer, and Steven P Sinkins, and Massimo Palmarini, and Sam J Wilson
March 1972, Science (New York, N.Y.),
Suzannah J Rihn, and Muhamad Afiq Aziz, and Douglas G Stewart, and Joseph Hughes, and Matthew L Turnbull, and Mariana Varela, and Elena Sugrue, and Christie S Herd, and Megan Stanifer, and Steven P Sinkins, and Massimo Palmarini, and Sam J Wilson
January 1966, Bulletin - Office international des epizooties,
Suzannah J Rihn, and Muhamad Afiq Aziz, and Douglas G Stewart, and Joseph Hughes, and Matthew L Turnbull, and Mariana Varela, and Elena Sugrue, and Christie S Herd, and Megan Stanifer, and Steven P Sinkins, and Massimo Palmarini, and Sam J Wilson
January 1964, Proceedings, annual meeting of the United States Animal Health Association,
Suzannah J Rihn, and Muhamad Afiq Aziz, and Douglas G Stewart, and Joseph Hughes, and Matthew L Turnbull, and Mariana Varela, and Elena Sugrue, and Christie S Herd, and Megan Stanifer, and Steven P Sinkins, and Massimo Palmarini, and Sam J Wilson
July 1963, Journal of immunology (Baltimore, Md. : 1950),
Suzannah J Rihn, and Muhamad Afiq Aziz, and Douglas G Stewart, and Joseph Hughes, and Matthew L Turnbull, and Mariana Varela, and Elena Sugrue, and Christie S Herd, and Megan Stanifer, and Steven P Sinkins, and Massimo Palmarini, and Sam J Wilson
January 1967, Research in veterinary science,
Suzannah J Rihn, and Muhamad Afiq Aziz, and Douglas G Stewart, and Joseph Hughes, and Matthew L Turnbull, and Mariana Varela, and Elena Sugrue, and Christie S Herd, and Megan Stanifer, and Steven P Sinkins, and Massimo Palmarini, and Sam J Wilson
February 1967, Journal of ultrastructure research,
Suzannah J Rihn, and Muhamad Afiq Aziz, and Douglas G Stewart, and Joseph Hughes, and Matthew L Turnbull, and Mariana Varela, and Elena Sugrue, and Christie S Herd, and Megan Stanifer, and Steven P Sinkins, and Massimo Palmarini, and Sam J Wilson
January 1964, American journal of veterinary research,
Suzannah J Rihn, and Muhamad Afiq Aziz, and Douglas G Stewart, and Joseph Hughes, and Matthew L Turnbull, and Mariana Varela, and Elena Sugrue, and Christie S Herd, and Megan Stanifer, and Steven P Sinkins, and Massimo Palmarini, and Sam J Wilson
April 2023, The Veterinary clinics of North America. Equine practice,
Copied contents to your clipboard!